Irinotecan HCl
USP
USDMF No. 23522, USFDA Approved,
Mexican GMP, Stability Studies In Zone IVB.
Technical Data
|
M. Wt |
623.139 |
|
Molecular Formula |
C33H39ClN4O6 |
|
CAS Number |
100286-90-6 |
|
PubChem ID |
74990 |
|
InChI Key |
GURKHSYORGJETM-WAQYZQTGSA-N |
|
Smiles |
Cl.CCC1=C2C=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)[C@]2(O)CC)C1=O |
|
Documents |
USDMF No. 23522, USFDA Approved, |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Description
Irinotecan hydrochloride (anhydrous) is a hydrochloride obtained by combining irinotecan with one molar equivalent of hydrochloric acid. Used (in the form of its trihydrate) in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy.
Synonym
Irinotecan Hcl; Topotecin; Campto; Camptosar; CPT-11; CPT 11
Disclaimer
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
